company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1630000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1630000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,829000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6760000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20502000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,531000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27793000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26964000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2281000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,396000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1793000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28757000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28757000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28757000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28757000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104136000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104136000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:31:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7629000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7629000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1814000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1814000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5815000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6862000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20155000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,541000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27558000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21743000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18621000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,107000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3991000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14523000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,117409000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117409000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:49:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3925000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3925000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2381000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2381000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1544000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6890000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15935000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,436000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3467000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26728000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25184000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15208000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,445000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14714000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2260000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42158000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,121654000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121654000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,120500000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3259000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3259000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2277000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2277000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,982000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6077000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14703000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,186000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20966000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19984000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3182000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,225000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2924000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22908000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22908000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22908000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22908000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142693000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142693000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,143200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:55:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1557000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1557000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1902000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6029000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14978000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,197000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21204000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19302000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3211000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-243000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3434000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22736000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22736000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22736000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22736000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145965000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145965000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 21:55:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2076000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2076000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,89303000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,89303000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-87227000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-18996000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-45616000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-819000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3467000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-68898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18329000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3222000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2146000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5353000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139170725.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,139170725.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139400000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2189000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2189000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,791000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,791000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1398000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6355000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14470000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,176000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21001000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19603000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4701000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2288000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6974000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2824000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29401000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,164213000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,164213000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,163300000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21977000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21977000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20117000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20117000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1860000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1860000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7157000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16827000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23959000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22099000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22099000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22099000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22099000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190272000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190272000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,184200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 17:34:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1485000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1485000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20575000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20575000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-19090000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19090000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1804000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5332000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3569000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15521000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15521000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15521000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15521000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213881000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213881000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,221700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 15:49:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1936000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1936000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43217000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43217000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-41281000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-6355000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-14470000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-176000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-21001000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1796000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,758000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,196523708.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,196523708.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2373000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2373000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2118000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2118000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7251000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14008000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21259000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21004000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1787000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3891000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2128000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,217503000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217503000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68927000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68927000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29021000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29021000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39906000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39906000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1778000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1956000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,194000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,40100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,217940000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224528000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222800000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:34:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3578000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3578000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1092000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1092000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2486000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7760000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14592000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19866000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1768000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4406000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2666000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218316000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218316000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:57:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6516000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6516000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,72098000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,72098000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-65582000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-15011000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-28600000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-43611000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21971000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1758000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,249000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1488000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218104323.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218104323.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215900000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6814000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6814000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-23538000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23538000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1747000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1717000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219222000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219222000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210500000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12801000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12801000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2010000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2010000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10791000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9132000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27025000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36157000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25366000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1735000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34557000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,32846000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7480000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7480000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7480000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7480000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225341000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,249300000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:30:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8164000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8164000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1836000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1836000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6328000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8029000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24508000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32537000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26209000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1723000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17244000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15537000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10672000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10672000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10672000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10672000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219866000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219866000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213400000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:24:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9191000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9191000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-26439000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-26439000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35630000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16976000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48814000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65790000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30160000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1710000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-205000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1901000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32061000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32061000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32061000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32061000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219734000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219734000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12256000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12256000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3593000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3593000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8663000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8439000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21968000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30407000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21744000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1696000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-889000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2551000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,235703000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,235703000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,243000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9181000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9181000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3115000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3115000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6066000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8844000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24201000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33045000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26979000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1754000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1892000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,172000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242067000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,242067000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,243700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:41:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9138000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9138000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3219000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3219000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5919000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9028000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22072000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25181000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1683000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,37000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,409000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1237000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26418000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26418000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26418000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26418000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242257000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,242257000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,240200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:06:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-17177000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-17177000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-9927000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-9927000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-7250000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3970000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15042000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3346000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22358000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29608000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1695000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1937000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3579000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33187000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33187000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2728000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.27
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.27
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24067000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.27
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9847000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9847000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3616000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3616000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6231000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6924000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18502000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25426000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19195000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1679000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,88000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-762000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2353000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21548000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21548000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21548000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21548000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,242876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,239400000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9512000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9512000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2609000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2609000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6903000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8465000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18546000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6115000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33126000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26223000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1619000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,554000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-960000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24308000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24308000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24300000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:07:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.12
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19242000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19242000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2812000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2812000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16430000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8590000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17466000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,231000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26287000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9857000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1609000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,54000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1067000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2622000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12479000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12479000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12479000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-122000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12357000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24325000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24325000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53562000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53562000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-9037000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-9037000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62599000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3550000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9268000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-231000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12587000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50012000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1605000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,460000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1102000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48910000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48910000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-10596000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-258000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38572000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.59
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.59
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24313000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.59
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1660000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1660000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1660000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7520000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15344000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22864000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21204000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1570000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,189000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1347000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22551000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22551000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,54000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22497000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-444000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22053000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24500000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24500000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24482000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7150000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24850000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22952000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1538000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-811000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23763000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23763000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,147000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23616000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-299000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23317000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30300000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.77
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30300000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30299000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:16:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.77
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7948000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7948000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2961000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2961000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4987000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7791000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17307000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11975000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37073000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32086000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1516000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,925000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-578000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32664000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32664000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32664000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32353000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37766000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37766000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37600000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,2017-11-08 16:11:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9831000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9831000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-2961000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-2961000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12792000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7880000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20637000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28517000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15725000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1495000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,429000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-85000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1151000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2921000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13955000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-271000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13684000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32990000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32990000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11151000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21573000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32724000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30969000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1472000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,774000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,534000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-164000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31133000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31133000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-830000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31963000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31963000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39996000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39996000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3994000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3994000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3994000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10405000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37160000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33166000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1448000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2502000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,279000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1333000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49263000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49263000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 18:25:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3573000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3573000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3573000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10766000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28811000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36004000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1423000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2524000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,589000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1690000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49368000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49368000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49000000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 08:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8648000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8648000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2467000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2467000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6181000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12935000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37890000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50825000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44644000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2972000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1470000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3090000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41554000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-110265000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,68711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,68711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,68711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47041000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.46
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47041000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.46
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.46
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,801057000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,801057000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14573000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14573000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,786484000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16578000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45396000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61974000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,724510000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1241000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6487000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5957000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,730467000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,110333000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,620134000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,620134000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,620134000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49478000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,12.53
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.1
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49500000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.53
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1022000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1022000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1022000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18367000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51211000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69578000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68556000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1222000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7595000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,780000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7153000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49653000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.24
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49653000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.24
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49500000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 18:25:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.24
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1350000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1350000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1350000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20428000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60257000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80685000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-79335000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1203000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6889000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,784000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6470000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-72865000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72865000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72865000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72865000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49864000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.46
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49864000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.46
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49900000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 08:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.46
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3002000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3002000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3002000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22243000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74632000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96875000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-93873000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1125000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5901000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,786000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5562000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-88311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-88311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49779000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.84
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51698000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.71
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49800000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.84
